Daichi Watanabe
Overview
Explore the profile of Daichi Watanabe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sato Y, Tanaka Y, Takaha R, Suetsugu T, Asai R, Imai T, et al.
Oncol Lett
. 2025 Feb;
29(3):159.
PMID: 39911148
The appropriate treatment strategy for esophageal squamous cell carcinoma (ESCC) in older patients remains unclear. The efficacy of preoperative chemotherapy using a divided-dose regimen of biweekly docetaxel, cisplatin and 5-fluorouracil...
2.
Adachi M, Horita R, Miwa T, Tajirika S, Imamura N, Watanabe D, et al.
J Autism Dev Disord
. 2024 Oct;
PMID: 39412584
Students with developmental disabilities are anxious about a change in environment when graduating from high school to college. Existing research, which is scarce, focuses on the mental health status of...
3.
Ikeda Y, Watanabe D, Oomori G, Yamada S, Okuda T, Minami S
Endosc Ultrasound
. 2024 Sep;
13(3):198-200.
PMID: 39318653
No abstract available.
4.
Watanabe D, Iihara H, Kobayashi R, Fujii H, Mori R, Kumada K, et al.
Front Oncol
. 2024 Aug;
14:1414037.
PMID: 39132500
Background: The effectiveness of a dexamethasone-sparing strategy in the treatment of breast cancer with anthracycline-cyclophosphamide therapy when combined with first-generation 5-HT3 receptor antagonists (RAs) and neurokinin-1 RAs is unclear. This...
5.
Fujii H, Makiyama A, Nishimura K, Iihara H, Hirose C, Ohata K, et al.
J Pharm Health Care Sci
. 2024 Jul;
10(1):36.
PMID: 38987837
Background: Anamorelin is expected to improve cancer cachexia by increasing lean body mass (LBM) due to increased appetite and protein synthesis. However, the effect of anamorelin on cancer cachexia in...
6.
Fuwa M, Tamai Y, Kato A, Asano M, Mori I, Watanabe D, et al.
J Clin Med
. 2024 Jun;
13(11).
PMID: 38892959
The use of serum soluble interleukin 2 receptor (sIL-2R) for the diagnosis of febrile illnesses has not been examined. In this study, febrile patients were classified according to etiology and...
7.
Sakamoto T, Oda I, Okamura T, Cho H, Toyoshima N, Nonaka S, et al.
DEN Open
. 2024 May;
5(1):e381.
PMID: 38725875
Accurate measurement of the size of lesions or distances between any two points during endoscopic examination of the gastrointestinal tract is difficult owing to the fisheye lens used in endoscopy....
8.
Fujii H, Tsuchiya M, Watanabe D, Otsuka R, Hirate D, Takahashi K, et al.
Support Care Cancer
. 2024 Apr;
32(5):291.
PMID: 38630197
Background: Trifluridine/tipiracil (TAS-102) is an oral anticancer drug with adequate efficacy in unresectable colorectal cancer, but frequently also induces chemotherapy-induced nausea and vomiting (CINV). To investigate the occurrence of CINV...
9.
Kakita S, Watanabe T, Yamagishi J, Tanaka C, Watanabe D, Okura H
Healthcare (Basel)
. 2024 Apr;
12(7).
PMID: 38610206
Increased physical activity may prevent disease onset and severity in individuals with cardiovascular disease. However, studies evaluating physical activity in people with cardiovascular disease are limited. This prospective observational study...
10.
Tanaka Y, Sato Y, Horaguchi T, Fujibayashi S, Yasufuku I, Miyoshi T, et al.
Anticancer Res
. 2024 Mar;
44(4):1661-1674.
PMID: 38537992
Background/aim: Progress has been made in a triplet preoperative chemotherapy regimen for advanced esophageal cancer. We performed a preliminary investigation of the radiomics features of pathological lymph node metastasis after...